PreludeDx Secures FDA Breakthrough for AidaBREAST Test
LAGUNA HILLS, CALIFORNIA, April 29, 2026 PreludeDx has announced that the U.S. Food and Drug Administration (FDA) has granted...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
LAGUNA HILLS, CALIFORNIA, April 29, 2026 PreludeDx has announced that the U.S. Food and Drug Administration (FDA) has granted...
SYDNEY, Australia & NEW YORK, United States, April 8, 2026 Lumonus, a healthcare technology company specializing in AI-driven radiation...
San Antonio, Texas, March 26, 2026 In a strategic move to address critical gaps in radiation emergency therapeutics, Tivic...
